Agenda - India Pharma Summit
Transcription
Agenda - India Pharma Summit
DepartmentofPharmaceuticals MinistryofChemicalsandFertilizers GovernmentofIndia INDIAPHARMASUMMIT2014‐15 PolicyLandscapeReformsforStrengtheningIndianPharmaceuticalIndustry “FocusonCriticalVerticalstoFosterAccesstoPharmaceuticals,EnhancingProductionand TechnologyAdoptioninPharmaceuticalEnterprises&MedicalDevicesandDiagnostics” 23rdMarch,2015,HotelRamadaPlazaPalmGrove,JuhuBeach,Mumbai DRAFTPROGRAMME 08:30‐09:30Hrs:Registration 09:30‐09:45Hrs:Seating 9:45‐11:00Hrs 09:45‐09:55Hrs 09:55‐10:05Hrs 10:05–10:15Hrs 10:15–10:25Hrs 10:25‐10:35Hrs 10:35‐10:50Hrs 10:50‐10:53HRS 10:53–11:00Hrs 11:00‐11:15Hrs Inauguralsession SessionModerator–Ms.ShobhaMishraGhosh,Sr.Director,FICCI IntroductoryRemarks Mr.SudhanshPant,JointSecretary,DepartmentofPharmaceuticals OpeningAddress DrNataMenabde,WHORepresentativetoIndia SpecialAddress DrHabilKhorakiwala,ChairmanFICCILifeSciencesCouncil,PastPresident FICCIandChairmanWockhardtGroup SpecialAddress Mr.SatishReddy,Chairman,Dr.Reddy’sLaboratories KeynoteAddress Dr.VKSubburaj,Secretary,DepartmentofPharmaceuticals InauguralAddress ShriHansrajGangaramAhir,Hon’bleUnionMinisterforStatefor Chemicals&Fertilizers ReleaseofPositionPaper ConcludingRemarks Dr.ArbindPrasad,DirectorGeneral,FICCI TeaBreak DepartmentofPharmaceuticals MinistryofChemicalsandFertilizers GovernmentofIndia 11:15‐12:30Hrs SessionI Critical Verticalsto Foster AccesstoPharmaceuticalsat Nationaland Internationallevels Chair:DrV.K.Subburaj,Secretary,DepartmentofPharmaceuticals Co‐Chair:Dr.M.ArizAhammed,JointSecretary,Departmentof Pharmaceuticals Presentationby: 12:30‐13:30Hrs MrFransStobbelaar,Advisor,WHOIndiaCountryOffice Mr Aditya Vijay Kumar Berlia, Co‐Chair FICCI Pharma Committee and MemberManagementBoard,ApeejaySatya Panelists: Mr.DGShah,SecretaryGeneral,IndianPharmaceuticalAlliance Mr.DaaraPatel,SecretaryGeneral,IDMA Mr.SudarshanJain,VicePresident,OPPIandManagingDirector,Abbott IndiaLimited LunchBreak 13:30‐14:50Hrs SessionII Promoting Production and Technology adoption in Pharmaceutical EnterprisesforMeetingNationalandGlobalPublicHealthNeeds Chair:Mr.RajivYadav,SpecialSecretaryandFinancialAdvisor, DepartmentofPharmaceuticals Co‐Chair:Mr.SudhanshPant,JointSecretary,Departmentof Pharmaceuticals Presentationby: DrMadhurGupta,TechnicalOfficer‐Pharmaceuticals,WHOIndia CountryOffice Mr.RehanKhan,Co‐ChairFICCIPharmaCommitteeandManaging Director,AbbottLimited Panelists: DrManishaShridhar,RegionalAdvisor,TradeandHealth,WHOSEARO Mr S V Veeramani, President IDMA and Managing Director, Forturrs Labs.Pvt.Ltd. Mr. Ashutosh Gupta, Chairman Pharmexcil and Managing Director, DepartmentofPharmaceuticals MinistryofChemicalsandFertilizers GovernmentofIndia MedicamenBiotechLimited. 14:50‐16:15Hrs SessionIII RegulatoryissuesandchallengesforMedicalDevicesandDiagnostics Chair:Mr.AmitKhare,MemberSecretary,NPPA Co‐Chair: Dr.S.EswaraReddy,DeputyDrugsController(lndia) Presentationby: DrJoseeHansen,SeniorAdvisor,DepartmentofEssentialMedicines andHealthProducts,WHOGeneva Mr.SushobhanDasgupta,ChairFICCIMedicalDeviceForumand ManagingDirector,Johnson&JohnsonMedicalIndia Panelists: Dr.G.S.Bhuvaneshwar‐Director,TrivitronHealthcarePvt.Ltd. Mr.AjayPitre,Co‐chairFICCIMedicalDevicesForumandManaging Director,PitreBusinessVenturesPvt.Ltd. DrJitendraSharma,Head,DivisionofHealthcareTechnology, NationalHealthSystemsResourceCentre,MinistryofHealth& FamilyWelfare TeaBreak 16:15‐16:30Hrs 16:30‐17:30Hrs ValedictoryAddress VisionStatementsby Mr.DilipShanghvi,ManagingDirector,SunPharma DrHabilKhorakiwala,ChairmanFICCILifeSciencesCouncil,Past PresidentFICCIandChairmanWockhardtGroup DrNataMenabde,WHORepresentativetoIndia Mr.SudhanshPant,JointSecretary,DepartmentofPharmaceuticals Dr.M.ArizAhammed,JointSecretary,Departmentof Pharmaceuticals *ToBeConfirmed 20‐03‐2015